Complement-Dependent Cytotoxicity

Complement-dependent cytotoxicity (CDC) is when antibodies on a target cell trigger the complement system to build a membrane attack complex and lyse that cell. In Microbiology, it shows how immune proteins can directly kill microbes or tagged cancer cells.

What is Complement-Dependent Cytotoxicity?

Complement-dependent cytotoxicity, or CDC, is a way the immune system directly kills a target cell after antibodies bind to its surface. Once those antibodies are in place, they can activate the classical complement pathway, which ends with a membrane attack complex forming a pore in the membrane.

That pore matters because it breaks the cell’s barrier function. Water and ions move in the wrong direction, the membrane loses control of what gets in and out, and the cell can undergo osmotic lysis. So CDC is not just “immune attack” in a vague sense, it is a very specific chain of binding, activation, pore formation, and rupture.

In Microbiology, this comes up when you study how the immune system targets microbes and abnormal cells. The trigger is usually antibody attachment, which means CDC sits at the intersection of adaptive immunity and innate effector mechanisms. Antibodies do the targeting, but complement does the physical damage.

The sequence is what makes CDC easy to trace on a quiz or in a diagram. First, an antibody recognizes an antigen on the target cell. Then complement proteins are activated in order, building a cascade that amplifies the response. Finally, the membrane attack complex, often abbreviated MAC, inserts into the membrane and creates the lethal hole.

CDC is especially relevant in cancer immunobiology because some monoclonal antibody therapies work by coating tumor cells and recruiting complement. But cells are not helpless in front of this system, since many cancers and pathogens evolve ways to reduce complement activation, block MAC assembly, or otherwise avoid lysis. That escape behavior is one reason complement-based killing can work well in some situations and fail in others.

Why Complement-Dependent Cytotoxicity matters in MICROBIO

CDC shows you how the immune system can kill a cell without needing a T cell to enter and destroy it from the inside. That makes it a useful bridge concept in Microbiology, because it links antibody binding, complement activation, and membrane damage in one pathway.

You will also see CDC when the course shifts into immunotherapy. Some monoclonal antibodies are designed to tag tumor-associated antigens, then recruit complement as part of their effect. If you can follow CDC, you can explain why the same antibody can do more than just block a receptor, it can also flag the cell for destruction.

It also gives you a concrete example of immune evasion. If a bacterium, virus-infected cell, or tumor cell prevents complement from finishing the cascade, it can survive longer even when antibodies are present. That makes CDC useful for comparing immune attack with immune escape.

In lab-style or case-based questions, CDC often shows up as a process to trace: what bound first, which pathway got activated, and what structure caused lysis.

How Complement-Dependent Cytotoxicity connects across the course

Complement System

CDC is one outcome of the complement system, especially the classical pathway. If you know the complement proteins are a cascade, CDC makes sense as the end result of that cascade: a target cell gets tagged, the proteins activate in sequence, and the final proteins assemble into a membrane pore.

Membrane Attack Complex (MAC)

The MAC is the structure that actually punches the hole in the target membrane. CDC is the broader process that leads to MAC formation, so when you see lysis in a diagram or case, the MAC is the final damage step you should identify.

Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

CDC and ADCC both start with antibodies on a target, which is why they are easy to mix up. The difference is the killer: CDC uses complement proteins and MAC, while ADCC uses immune cells like NK cells that bind the antibody tail and release toxic molecules.

Chimeric Antigen Receptor

CAR-based therapies are another way cancer cells can be targeted after they display specific antigens. CDC is not CAR therapy itself, but both concepts show how directing immune recognition toward a tumor marker can lead to cell death, either through complement or engineered immune cells.

Is Complement-Dependent Cytotoxicity on the MICROBIO exam?

A quiz question might show a coated cell and ask you to identify why it lyses, or it may describe a monoclonal antibody treatment and ask which immune mechanism is being triggered. Your job is to trace the sequence, antibody binds first, complement activates next, then MAC forms and damages the membrane.

In short-answer or case questions, you may need to compare CDC with ADCC or explain why a cancer cell survives despite antibody binding. If you see membrane pore formation, osmotic lysis, or classical complement activation in the prompt, CDC is the mechanism to test for. On diagrams, label the antibody-coated target, the complement cascade, and the MAC at the membrane.

Complement-Dependent Cytotoxicity vs Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

Both CDC and ADCC begin with antibodies attached to a target cell, so they look similar at first. CDC kills through complement proteins and the membrane attack complex, while ADCC kills through immune cells such as NK cells that recognize the antibody Fc region and release cytotoxic molecules.

Key things to remember about Complement-Dependent Cytotoxicity

• Complement-dependent cytotoxicity is antibody-triggered killing of a target cell through the complement system.

• The classical complement pathway leads to membrane attack complex formation, which punctures the membrane and causes osmotic lysis.

• CDC links adaptive immunity, through antibodies, with innate immune killing, through complement proteins.

• In Microbiology, CDC shows up in immune defense, monoclonal antibody therapy, and pathogen or tumor immune evasion.

• If you can trace the steps from antibody binding to MAC formation, you can recognize CDC in diagrams and case questions.

Frequently asked questions about Complement-Dependent Cytotoxicity

What is complement-dependent cytotoxicity in Microbiology?

Complement-dependent cytotoxicity is a mechanism where antibodies bound to a target cell activate complement proteins, leading to membrane attack complex formation and cell lysis. In Microbiology, this is a classic example of how the immune system can directly destroy a marked cell.

How does complement-dependent cytotoxicity kill a cell?

Antibodies first bind antigens on the cell surface, then the classical complement pathway activates. The cascade builds the membrane attack complex, which inserts into the membrane and creates a pore that disrupts osmotic balance and kills the cell.

What is the difference between CDC and ADCC?

CDC uses complement proteins to lyse the target, while ADCC uses immune cells like NK cells to kill it. They both depend on antibodies, but the actual killing mechanism is different, so the final step is the easiest way to tell them apart.

Where does complement-dependent cytotoxicity show up in cancer treatment?

Some monoclonal antibodies used in cancer therapy can coat tumor cells and recruit complement, which helps destroy those cells through CDC. Tumors can resist this by reducing complement activation or blocking membrane attack complex formation.